rank	phenotype	cui	assoc in neigh	assoc in intom	probability	Benjamini-Hochberg	genes	
13	Episodic ataxia	C1720189	2	25	4.59424649435e-08	5.241935483870968e-05	ATP1A2,ATP1A3
14	Tetraplegia	C0034372	2	26	5.19336960103e-08	5.6451612903225804e-05	ATP1A2,ATP1A3
15	Tetraplegia/tetraparesis	C4022595	2	29	7.28838462916e-08	6.0483870967741935e-05	ATP1A2,ATP1A3
19	Hemiplegia	C0018991	2	31	8.96195800903e-08	7.661290322580645e-05	ATP1A2,ATP1A3
22	Headache	C0018681	3	204	2.67173022483e-07	8.870967741935484e-05	ATP1A4,ATP1A2,ATP1A1
23	Choreoathetosis	C0085583	2	52	4.39313863843e-07	9.274193548387098e-05	ATP1A2,ATP1A3
27	Sensorineural hearing impairment	C0018784	4	673	6.48523656333e-07	0.00010887096774193549	ATP1A2,ATP1A1,ATP1B1,ATP1A3
28	Hemiparesis	C0018989	2	63	7.88171640731e-07	0.00011290322580645161	ATP1A2,ATP1A3
31	Primary hyperaldosteronism	C1384514	2	65	8.66666862054e-07	0.000125	ATP1A4,ATP1A1
34	Essential hypertension	C0085580	3	305	1.33124160928e-06	0.00013709677419354837	ATP1A4,ATP1A1,ATP1B1
35	Hypertension	C0020538	5	1647	1.75717734774e-06	0.00014112903225806453	FXYD2,ATP1A4,ATP1A2,ATP1A1,ATP1B1
40	Incomplete penetrance	C1836598	2	84	1.88529172551e-06	0.00016129032258064516	ATP1A2,ATP1A3
41	Type 1 diabetic neuropathy	C0011882	2	90	2.32243163012e-06	0.0001653225806451613	ATP1A4,ATP1A1
42	Vesicular Stomatitis	C0266999	2	97	2.91173556588e-06	0.00016935483870967742	ATP1A4,ATP1A1
43	Paresthesia	C0030554	2	97	2.91173556588e-06	0.00017338709677419356	ATP1A4,ATP1A1
44	Neurologic Symptoms	C0235031	2	98	3.00322870783e-06	0.0001774193548387097	ATP1A2,ATP1A3
47	Severe Acute Respiratory Syndrome	C1175175	2	99	3.09659183129e-06	0.00018951612903225806	ATP1A4,ATP1A1
51	Chorea, childhood-onset, with psychomotor retardation	C0008489	2	109	4.13857593895e-06	0.00020564516129032258	ATP1A2,ATP1A3
61	Congenital Myotonic Dystrophy	C0410226	2	153	1.14635829835e-05	0.0002459677419354839	ATP1A1,ATP1A3
64	Steinert myotonic dystrophy syndrome	C0027126	2	160	1.31079751284e-05	0.00025806451612903227	ATP1A1,ATP1A3
66	Hemiplegia/hemiparesis	C0375206	2	166	1.46357427591e-05	0.00026612903225806453	ATP1A2,ATP1A3
72	Mental deterioration	C0234985	2	192	2.26154819162e-05	0.0002903225806451613	ATP1A2,ATP1A3
73	Drooling	C0013132	1	26	2.76616817068e-05	0.00029435483870967743	ATP1A3
74	Endothelial dysfunction	C0856169	2	216	3.21433148732e-05	0.0002983870967741936	ATP1A4,ATP1A1
75	Blurred vision	C0344232	1	28	3.21625958586e-05	0.0003024193548387097	ATP1A2
76	Truncal ataxia	C0427190	1	28	3.21625958586e-05	0.0003064516129032258	ATP1A3
77	Chondrocalcinosis	C0553730	1	29	3.45395620837e-05	0.00031048387096774195	FXYD2
78	Retrocollis	C0040485	1	32	4.21763820462e-05	0.00031451612903225806	ATP1A3
79	Motor symptoms	C0426980	1	33	4.48903790436e-05	0.0003185483870967742	ATP1A3
80	Excessive salivation	C0037036	1	34	4.76885743934e-05	0.0003225806451612903	ATP1A3
81	Dysphasia	C0973461	1	37	5.65877498586e-05	0.0003266129032258064	ATP1A2
82	Progressive sensorineural hearing impairment	C1843156	1	39	6.29404873899e-05	0.0003306451612903226	ATP1A3
83	Aphasia	C0003537	1	39	6.29404873899e-05	0.0003346774193548387	ATP1A2
84	Gait instability, worse in the dark	C0231686	1	39	6.29404873899e-05	0.00033870967741935485	ATP1A3
85	Bipolar affective disorder	C0005586	3	817	6.50272421034e-05	0.00034274193548387095	ATP1A2,ATP1A1,ATP1A3
86	Confusion	C0009676	1	41	6.962901925e-05	0.0003467741935483871	ATP1A2
87	Weakness due to upper motor neuron dysfunction	C4021255	2	284	7.2575324496e-05	0.00035080645161290327	ATP1A2,ATP1A3
88	Hyperaldosteronism, familial, type IV	C0020428	1	43	7.66528187218e-05	0.0003548387096774194	ATP1A1
89	Craniofacial dystonia	C4023011	1	45	8.40117063555e-05	0.0003588709677419355	ATP1A3
90	Bradykinesia	C0233565	1	47	9.17053585023e-05	0.00036290322580645164	ATP1A3
91	Progressive hearing impairment	C1837645	1	48	9.56775929842e-05	0.00036693548387096774	ATP1A3
92	Dystonia 2, torsion, autosomal recessive	C0013421	2	314	9.77558184504e-05	0.0003709677419354839	ATP1A2,ATP1A3
93	Dysarthria	C0013362	2	335	0.0001184143621	0.000375	ATP1A2,ATP1A3
94	Focal dystonia	C0743332	1	56	0.000130460357814	0.0003790322580645161	ATP1A3
95	Abnormality of the musculature of the neck	C4023601	1	59	0.000144878584614	0.00038306451612903227	ATP1A3
96	Progressive visual loss	C1839364	1	66	0.000181428747637	0.0003870967741935484	ATP1A3
97	Generalized hypotonia	C1858120	1	67	0.000186981965721	0.00039112903225806453	ATP1A3
98	Common Migraine	C0338480	1	70	0.000204138260586	0.00039516129032258064	ATP1A2
99	Decreased facial expression	C1862474	1	70	0.000204138260586	0.00039919354838709674	ATP1A3
100	Ventricular Dysfunction, Right	C0242973	1	71	0.000210022448445	0.0004032258064516129	ATP1A3
101	Vertigo	C0042571	1	73	0.000222038863039	0.00040725806451612906	ATP1A2
102	Abnormal facial expression	C4025209	1	76	0.000240682543111	0.00041129032258064517	ATP1A3
103	Migraine with aura	C0154723	1	77	0.000247062170854	0.0004153225806451613	ATP1A2
104	Dysmetria	C0234162	1	78	0.000253524162511	0.00041935483870967743	ATP1A3
105	Phenotypic variability	C1837514	2	434	0.00025426104833	0.0004233870967741936	ATP1A2,ATP1A3
106	Gait ataxia	C0751837	1	80	0.000266695196805	0.0004274193548387097	ATP1A3
107	Abnormality of salivation	C4021978	1	81	0.000273404215305	0.0004314516129032258	ATP1A3
108	Vestibular dysfunction	C1843865	1	82	0.000280195527395	0.00043548387096774196	ATP1A2
109	Autosomal dominant non-syndromic sensorineural deafness type DFNA	C0443147	3	1262	0.000350519639101	0.00043951612903225806	FXYD2,ATP1A2,ATP1A3
110	Coma	C0009421	1	93	0.000360318114129	0.0004435483870967742	ATP1A2
111	Generalized tonic-clonic seizures	C0494475	1	95	0.000375950651132	0.0004475806451612903	ATP1A2
112	Abnormal urinary electrolyte concentration	C4022833	1	97	0.000391910172026	0.00045161290322580643	FXYD2
113	Involuntary movements	C0427086	2	507	0.000401399853359	0.0004556451612903226	ATP1A2,ATP1A3
114	Emotional lability	C0085633	1	100	0.00041646158071	0.0004596774193548387	ATP1A3
